4.6 Article

The SCFβ-TrCP Ubiquitin Ligase Regulates Immune Receptor Signaling by Targeting the Negative Regulatory Protein TIPE2

Journal

JOURNAL OF IMMUNOLOGY
Volume 204, Issue 8, Pages 2122-2132

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1901142

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [81871309, 31500707, U1804190]
  2. Xinxiang Medical University [505248]

Ask authors/readers for more resources

TNFAIP8-like 2 (TIPE2) is a negative regulator of immune receptor signaling that maintains immune homeostasis. Dysregulated TIPE2 expression has been observed in several types of human immunological disorders. However, how TIPE2 expression is regulated remains to be determined. We report in this study that the SCF beta-TrCP ubiquitin ligase regulates TIPE2 protein abundance by targeting it for ubiquitination and subsequent degradation via the 26S proteasome. Silencing of either cullin-1 or beta-TrCP1 resulted in increased levels of TIPE2 in immune cells. TAK1 phosphorylated the Ser(3) in the noncanonical degron motif of TIPE2 to trigger its interaction with beta-TrCP for subsequent ubiquitination and degradation. Importantly, the amount of TIPE2 protein in immune cells determined the strength of TLR 4-induced signaling and downstream gene expression. Thus, our study has uncovered a mechanism by which SCF beta-TrCP E3 ubiquitin ligase regulates TLR responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available